Connect Biopharma Holdings Free Cash Flow (FCF) History (CNTB)
Connect Biopharma Holdings reported −$51.6M in free cash flow for fiscal 2025, a decrease of $27.3M from the previous fiscal year, with a free cash flow margin of −80687.50%.
View full Connect Biopharma Holdings company overviewConnect Biopharma Holdings free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$51.6M | −$27.3M | — | −80687.50% |
| 2024 | 2024-12-31 | −$24.4M | $23.5M | — | −93.58% |
| 2023 | 2023-12-31 | −$47.8M | $58.1M | — | — |
| 2022 | 2022-12-31 | −$105.9M | −$17.8M | — | — |
| 2021 | 2021-12-31 | −$88.2M | — | — | — |
Connect Biopharma Holdings quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$15.9M | −$3.0M | — | −575.22% |
| Q1 2026 | 2026-03-31 | −$16.0M | −$6.0M | — | −9470.41% |
| Q4 2025 | 2025-12-31 | −$11.3M | −$8.6M | — | — |
| Q3 2025 | 2025-09-30 | −$17.4M | −$4.3M | — | −109000.00% |
| Q2 2025 | 2025-06-30 | −$12.9M | −$4.9M | — | −26862.50% |
| Q1 2025 | 2025-03-31 | −$10.0M | −$9.4M | — | — |
| Q4 2024 | 2024-12-31 | −$2.6M | — | — | — |
| Q3 2024 | 2024-09-30 | −$13.2M | — | — | −1079.08% |
| Q2 2024 | 2024-06-30 | −$8.0M | — | — | −33.11% |
| Q1 2024 | 2024-03-31 | −$591,000 | — | — | — |
Connect Biopharma Holdings free cash flow growth trends
Connect Biopharma Holdings's latest reported quarter, Q2 2026, generated −$15.9M in free cash flow, a decrease of $3.0M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Connect Biopharma Holdings filings at SEC.gov ↗